What is the global market size of Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2021 and is poised to grow from USD 5806.48 billion in 2022 to USD 12018.88 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030).

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Size, Share, Growth Analysis, By Product(Reagents and consumables, instruments), By Technology(Digital PCR (dPCR), and quantitative PCR (qPCR)), By Application(Research applications, clinical applications), By End-user(Hospitals & diagnostic centers, research laboratories & academic institutes) - Industry Forecast 2024-2031

Report ID: SQMIG35J2038 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 117 | Figures: 77

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Insights

Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2019 and is poised to grow from USD 5806.48 billion in 2023 to USD 12018.88 billion by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

Real-time PCR and digital PCR are widely used to detect and quantify nucleic acids; and the applications of the techniques support measuring minor variants within the genetic material. The real-time PCR is a technique that is quite known to people, and is a well-established technology for the rapid, sensitive quantification of nucleic acid in various biological samples, while digital PCR delivers an absolute measure of target nucleic acid molecules. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). The increasing prevalence of genetic and infectious diseases, technological advancement in PCR, forensic, & other research laboratories are propelling the growth of dPCR and qPCR market. Whereas, the technical limitations related with PCR and usage of alternative assays to discover diseases may likely obstruct the market growth.

US Digital PCR (dPCR) and Real-time PCR (qPCR) Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global digital PCR (dPCR) and real-time PCR (qPCR) market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Thermo Fisher Scientific Inc.', 'Bio-Rad Laboratories, Inc.', 'QIAGEN N.V.', 'F. Hoffmann-La Roche Ltd.', 'Agilent Technologies, Inc.', 'Fluidigm Corporation', 'Merck KGaA', 'Takara Bio Inc.', 'Illumina, Inc.', 'Promega Corporation', 'Abbott Laboratories', 'Danaher Corporation', 'Becton, Dickinson and Company', 'GE Healthcare Life Sciences', 'Eppendorf AG', 'Analytik Jena AG', 'Enzo Biochem, Inc.', 'Luminex Corporation', 'BioFire Diagnostics, Inc.', 'Oxford Nanopore Technologies Ltd.'

Several factors are responsible for the growth of the global digital PCR (dPCR) and real-time PCR (qPCR) market including growing prevalence of infectious diseases, increasing genetic disorders, and the successful execution of Human Genome project during the forecast period.

Increasing number of patients caused due to viral infections/diseases increased concerns in the healthcare sector. As a result, digital PCR techniques are on the trend for discovering the drug or biomarker for the viral diseases. Moreover, due to the improvement in digital PCR techniques, it helps to detect the rare cancer biomarkers. Thus, researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to find out the new cancer biomarkers.

North America is holding the largest market share with a revenue of more than 35.0% in 2021, and is still expected to retain the same during the forecast period, owing to the presence of supportive government regulations and various initiatives about the development of healthcare infrastructure, growing prevalence of infectious and genetic diseases in the region, and an availability of the key manufacturers in the region are all expected to drive the regional market over the forecast period. The United States and Canada are the prominent countries boosting the market growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Insights

Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Who are the key vendors in the Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

What is the key driver of Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

What is the key market trend for Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Which region accounted for the largest share in Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300